Loreclezole

File:Loreclezole.svg

Loreclezole.svg

Loreclezole is a pharmaceutical drug that belongs to the class of anticonvulsants. It is primarily used in the treatment of epilepsy and other seizure disorders. Loreclezole functions by modulating the activity of gamma-aminobutyric acid (GABA), a key inhibitory neurotransmitter in the central nervous system.

Mechanism of Action

Loreclezole enhances the effects of GABA by binding to the GABA_A receptor and increasing the duration of chloride ion channel opening. This action results in hyperpolarization of the neuronal membrane, making it less likely to fire and thereby reducing the likelihood of a seizure.

Pharmacokinetics

Loreclezole is well-absorbed after oral administration and has a bioavailability of approximately 80%. It is metabolized in the liver primarily by the cytochrome P450 enzyme system and is excreted mainly via the kidneys. The half-life of loreclezole is approximately 12 hours, allowing for twice-daily dosing.

Indications

Loreclezole is indicated for the management of various types of epilepsy, including:

• Partial seizures
• Generalized tonic-clonic seizures
• Absence seizures

Side Effects

Common side effects of loreclezole include:

• Drowsiness
• Dizziness
• Nausea
• Headache

Serious side effects may include:

• Hepatotoxicity
• Stevens-Johnson syndrome
• Agranulocytosis

Contraindications

Loreclezole is contraindicated in patients with:

• Known hypersensitivity to loreclezole or any of its components
• Severe liver disease
• Severe renal impairment

Drug Interactions

Loreclezole may interact with other medications, including:

• Other anticonvulsants
• Benzodiazepines
• Alcohol

Monitoring

Patients on loreclezole should be regularly monitored for liver function, renal function, and complete blood counts to detect any potential adverse effects early.

See Also

• Epilepsy
• Anticonvulsant
• GABA_A receptor
• Seizure

External Links

-